These changes were associated with marked and sustainable boosts in fatty acid oxidation, with suggested increases of up to 216% in murine models of obesity
( a ) Fasting plasma GIP (CON n = 11, Gipr AP-KO n = 12), ( b ) total GLP-1 (CON n = 11, Gipr AP-KO n = 12) ( c ) insulin (CON n = 11, Gipr AP-KO n = 12), ( d ) food intake post IPGTT, ( e ) ad lib fed blood glucose, ( f ) RER, ( g ) energy expenditure (inset, with ANCOVA using BW as covariate), ( h ) ambulatory activity (x beam breaks) of std chow fed (lean) mice ( d - h : CON n = 11, Gipr AP-KO n = 13, symbols as defined in f)
Bradley EH, Holmboe ES, Mattera JA, Roumanis SA, Radford MJ, Krumholz HM
The study found that many people regain weight quickly after stopping GLP-1 medications (like Wegovy or Mounjaro)
The Alarming Twist when using Ozempic for weight loss
There was no statistically significant difference in antihypertensive medication use between the groups